Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy-Reference-Cited by-同舟云学术

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy

Published:2016-03-04 Issue:2 Volume:5 Page:2
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Daruich Alejandra¹,Matet Alexandre¹,Dirani Ali¹,Gallice Mathilde¹,Nicholson Luke²,Sivaprasad Sobha²,Behar-Cohen Francine³

Affiliation:

1. Department of Ophthalmology, University of Lausanne. Jules-Gonin Eye Hospital. Fondation Asile des Aveugles, Avenue de France 15, CP 133 1000 Lausanne 7, Switzerland

2. NIHR Moorfields Biomedical Research Centre, 162 City Road, London EC1V 2PD, United Kingdom

3. Department of Ophthalmology, University of Lausanne. Jules-Gonin Eye Hospital. Fondation Asile des Aveugles, Avenue de France 15, CP 133 1000 Lausanne 7, Switzerland 3Sorbonne Universités, UPMC Université Paris 06, UMR 1138, Centre de Recherche des Cordel

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

Ophthalmology,Biomedical Engineering

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball;Materials Today Bio;2024-08

2. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07

3. Optical Coherence Tomography-Based Positive Predictors of Eplerenone Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Study;Cureus;2024-04-22

4. Efficacy and Predictive Factors of Oral Spironolactone Treatment in Chronic Central Serous Chorioretinopathy;Journal of Ophthalmology;2024-03-18

5. Subthreshold laser compared to oral spironolactone for the treatment of chronic central serous chorioretinopathy: a retrospective study;International Ophthalmology;2024-03-13